Diabetes type 2. Diabetes mellitus due to underlying condition
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, intervention in the form of pharmacist training to patients on how to manage medication, how to use medications, helping to reduce side e
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Starting diabetes medication for at least three months before the start of the study Three-month blood sugar above 7% at the beginning of the study Initiation of diabetes medication for at least three months before the start of the study
Exclusion criteria
Exclusion criteria: Type 1 diabetes Having diabetes in the context of taking drugs Diabetes during pregnancy in pregnant women Diabetes caused by cystic fibrosis Inability or mental disability in such a way that she is not able to cooperate and respond and cannot write and read
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin A1c. Timepoint: Baseline, three months later, six months later. Method of measurement: Blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigating the role of pharmacist interventions in the patient's cooperation in taking medicine. Timepoint: Baseline, and the sixth month. Method of measurement: Morisky Drug Treatment Adherence Questionnaire (MMAS-8). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGolnaz Alsadat Afzal
Yazd University of Medical Sciences
Outcome results
None listed